These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 974991)

  • 1. Urinary-bladder toxicity following pelvic irradiation and simultaneous cyclophosphamide therapy.
    Jayalakshmamma B; Pinkel D
    Cancer; 1976 Aug; 38(2):701-7. PubMed ID: 974991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hematuria and localized bladder damage following combined cyclophosphamide and local radiotherapy.
    Kende G; Wajsman Z; Thomas PR; Freeman AI
    J Surg Oncol; 1979; 12(2):169-74. PubMed ID: 491685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy and pelvic radiotherapy-induced bladder injury.
    Çetinel B
    Urologia; 2015 Oct; 82 Suppl 3():S2-5. PubMed ID: 26937514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal hemorrhagic cystitis induced by pelvic irradiation and cyclophosphamide therapy. Case reports and review.
    Price WE; Keldahl LR
    Minn Med; 1990 May; 73(5):39-41, 44. PubMed ID: 2113164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incoercible hemorrhagic cystitis induced by pelvic radiotherapy and simultaneous treatment with cyclophosphamide].
    González Enguita C; Gil Sanz MJ; Rodríguez Vela L; Pérez Salinas V; Roncalés Badal A; Allepuz Losa C; Martínez Bengoechea J; Rioja Sanz C; Rioja Sanz LA
    Actas Urol Esp; 1990; 14(2):128-31. PubMed ID: 2378268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy.
    Johnson WW; Meadows DC
    N Engl J Med; 1971 Feb; 284(6):290-4. PubMed ID: 4321778
    [No Abstract]   [Full Text] [Related]  

  • 7. Leimyosarcoma of the urinary bladder. 13 years after cyclophosphamide therapy for Hodgkin's disease.
    Seo IS; Clark SA; McGovern FD; Clark DL; Johnson EH
    Cancer; 1985 Apr; 55(7):1597-603. PubMed ID: 3978554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and late toxicity in radical radiotherapy for bladder cancer.
    Majewski W; Tarnawski R
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):598-609. PubMed ID: 19632819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental Dose to Pelvic Nodes in Bladder-Only Radiotherapy: Is It Clinically Relevant?
    Lewis S; Murthy V; Mahantshetty U; Shrivastava SK
    Technol Cancer Res Treat; 2017 Jun; 16(3):382-387. PubMed ID: 28168933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma of the urinary bladder in patients receiving cyclophosphamide.
    Wall RL; Clausen KP
    N Engl J Med; 1975 Aug; 293(6):271-3. PubMed ID: 1138180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.
    McCammon R; Rusthoven KE; Kavanagh B; Newell S; Newman F; Raben D
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):413-20. PubMed ID: 19362783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incoercible hematuria due to prolonged treatment with cyclophosphamide].
    Scetbon V
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):472-6. PubMed ID: 4804422
    [No Abstract]   [Full Text] [Related]  

  • 13. Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood.
    Yeung CK; Ward HC; Ransley PG; Duffy PG; Pritchard J
    Br J Cancer; 1994 Nov; 70(5):1000-3. PubMed ID: 7947075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and Severity of Acute Toxicity of Pelvic Radiotherapy for Gynecological Cancer.
    Hafiz A; Abbasi AN; Ali N; Khan KA; Qureshi BM
    J Coll Physicians Surg Pak; 2015 Nov; 25(11):802-6. PubMed ID: 26577965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis.
    Talar-Williams C; Hijazi YM; Walther MM; Linehan WM; Hallahan CW; Lubensky I; Kerr GS; Hoffman GS; Fauci AS; Sneller MC
    Ann Intern Med; 1996 Mar; 124(5):477-84. PubMed ID: 8602705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Normal tissue tolerance to external beam radiation therapy: bladder].
    Pointreau Y; Atean I; Durdux C
    Cancer Radiother; 2010 Jul; 14(4-5):363-8. PubMed ID: 20435498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intractable bladder haemorrhage due to bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy.
    Vlasveld LT; Bieger R
    Neth J Med; 1987 Jun; 30(5-6):287-94. PubMed ID: 3627313
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma.
    Xu Y; Wang H; Zhou S; Yu M; Wang X; Fu K; Qian Z; Zhang H; Qiu L; Liu X; Wang P
    Leuk Lymphoma; 2013 Jul; 54(7):1396-404. PubMed ID: 23101661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder leiomyosarcoma and pelvic fibroblastic tumor following cyclophosphamide therapy.
    Rowland RG; Eble JN
    J Urol; 1983 Aug; 130(2):344-6. PubMed ID: 6876288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide-induced hemorrhagic cystitis in Ewing's sarcoma.
    Stillwell TJ; Benson RC; Burgert EO
    J Clin Oncol; 1988 Jan; 6(1):76-82. PubMed ID: 3335893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.